Menopausal and femal climacteric state. Menopausal and other perimenopausal disorders
Conditions
Interventions
Treatment - Drugs
Salvia officinalis extract, 100 mg tablet, three times daily for 8 weeks.
Placebo, tablets 100 mg, three times daily, 8 weeks.
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Women between 45 to 60 years old who are less than 5 years after menopause; At least 12 months since last menstruation; At least three hot flushes daily; Written informed consent; No known physical or mental illness; Not using any medication with influence on menopausal symptoms within three month before the study start; BMI less than 29; No history of allergy to herbal medicine; No smoking or addiction; No use of medication with influence on menopausal symptoms. Exclusion criteria:Use of medication with influence on menopausal symptoms; Allergy to the medicine used or not used in the study; Patient reluctance
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hot flash. Timepoint: 1 week before the intervention and 8 weeks after intervention. Method of measurement: Questionnaire.;Night sweats. Timepoint: 1 week before the intervention and 8 weeks after intervention. Method of measurement: Questionnaire.;Estradiol. Timepoint: 1 week before the intervention and 8 weeks after intervention. Method of measurement: Laboratory pg per ml. | — |
Secondary
| Measure | Time frame |
|---|---|
| Menopausal Symptoms. Timepoint: 1 week before the intervention and 8 weeks after intervention. Method of measurement: Menopause Rating Scale questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSedighe Forouhari
Shiraz University of Medical Sciences
Outcome results
None listed